Image Gently : Is overuse of CT scans harming our children? FDA's new role in tobacco control : Guidance to empower youth to say no There's an app for that : Best mobile medical applications for pediatricians Dermcase : Squiggly blue line on dorsal foot Puzzler : Newborn not having very swell time Updates : Acyclovir and HSV, Substance abuse screening, PPIs for suspected infant GERD, Glucocorticoids and preterm infants, community-acquired Pneumonia
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.